• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Halobenzoic acids and derivatives

Introduction to 3-Carboxy-2-chlorophenylboronic Acid (CAS No. 1314264-58-8)

3-Carboxy-2-chlorophenylboronic acid is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound, identified by its unique Chemical Abstracts Service (CAS) number 1314264-58-8, is a boronic acid derivative featuring both a carboxylic acid functional group and a chlorophenyl moiety. These structural features make it a versatile intermediate in the synthesis of various bioactive molecules, particularly in the development of targeted therapeutics and advanced materials.

The significance of 3-carboxy-2-chlorophenylboronic acid lies in its utility as a building block for constructing complex molecular architectures. Boronic acids, in general, are well-known for their ability to participate in reversible coordination with diols, a property that has been leveraged in various applications, including drug delivery systems and catalysis. The presence of both the carboxylic acid and chlorophenyl groups in this compound enhances its reactivity and compatibility with a wide range of synthetic protocols, making it particularly valuable in medicinal chemistry.

In recent years, there has been growing interest in the development of boronic acid-containing compounds for their potential applications in therapeutic interventions. For instance, boron-containing compounds have been explored as precursors for radiopharmaceuticals used in positron emission tomography (PET) imaging, where their ability to form stable complexes with metals like boron-10 has been harnessed for diagnostic purposes. Additionally, boronic acids have shown promise as inhibitors of enzymes involved in metabolic pathways relevant to diseases such as cancer and diabetes.

The 3-carboxy-2-chlorophenylboronic acid derivative is particularly noteworthy due to its structural flexibility, which allows it to be incorporated into diverse molecular frameworks. This flexibility is crucial for designing molecules that can interact selectively with biological targets, thereby enhancing the efficacy and specificity of potential therapeutics. The carboxylic acid group can participate in hydrogen bonding interactions, while the chlorophenyl moiety can engage in π-stacking or other non-covalent interactions, providing multiple avenues for molecular recognition.

Recent advancements in computational chemistry have further highlighted the importance of 3-carboxy-2-chlorophenylboronic acid as a key intermediate. Molecular modeling studies have demonstrated that this compound can be effectively used to design small-molecule inhibitors targeting protein-protein interactions that are critical for disease pathogenesis. By leveraging the unique reactivity of its boronic acid functionality, researchers have been able to develop novel compounds with improved pharmacokinetic profiles and reduced off-target effects.

The synthesis of 3-carboxy-2-chlorophenylboronic acid typically involves multi-step organic transformations that require careful optimization to ensure high yields and purity. Common synthetic routes include halogenation of phenyl derivatives followed by carboxylation and subsequent boronation. The choice of starting materials and reaction conditions can significantly impact the overall efficiency of the process, necessitating rigorous experimental design and analytical characterization.

In the context of drug discovery, 3-carboxy-2-chlorophenylboronic acid has been utilized as a precursor for several lead compounds that are currently undergoing preclinical evaluation. Its incorporation into drug candidates has led to the identification of molecules with potent activity against various disease-related targets. For example, derivatives of this compound have shown inhibitory effects on kinases and other enzymes implicated in cancer progression, highlighting its potential as a scaffold for developing novel anticancer agents.

The role of 3-carboxy-2-chlorophenylboronic acid extends beyond pharmaceutical applications into materials science. Boronic acids are known for their ability to form coordination complexes with metals, which has led to their use in the development of metal-organic frameworks (MOFs) and other advanced materials. These materials exhibit unique properties such as high surface area, tunable porosity, and selective adsorption capabilities, making them attractive for applications in gas storage, separation technologies, and catalysis.

Recent research has also explored the use of 3-carboxy-2-chlorophenylboronic acid in biocatalysis and green chemistry initiatives. The ability of boronic acids to participate in environmentally friendly reactions has made them appealing for sustainable synthetic methodologies. For instance, enzymatic approaches involving boronic acid derivatives have been developed as alternatives to traditional chemical transformations, offering a more eco-friendly approach to industrial-scale production.

The future prospects for 3-carboxy-2-chlorophenylboronic acid are promising, with ongoing studies aimed at expanding its utility across multiple domains. Continued investigation into its reactivity patterns and synthetic applications will likely uncover new opportunities for its use in drug discovery, materials science, and beyond. As our understanding of molecular interactions evolves, compounds like 3-carboxy-2-chlorophenylboronic acid will continue to play a pivotal role in advancing scientific knowledge and technological innovation.

• 603122-80-1(2-chloro-4-(methoxycarbonyl)phenyl boronic acid)
• 352535-89-8((2,3-Dichloro-4-formylphenyl)boronic acid)
• 603122-82-3((3-Chloro-4-(methoxycarbonyl)phenyl)boronic acid)
• 136496-72-5(3-chloro-4-carboxyphenylboronic acid)
• 957061-05-1(3-Carboxy-5-chlorophenylboronic acid)
• 851335-09-6(4-borono-3-chlorobenzoic acid)
• 874219-46-2((4-Chloro-3-(ethoxycarbonyl)phenyl)boronic acid)
• 913835-75-3(5-Carboxy-2-chlorophenylboronic acid)
• 874219-45-1(4-Chloro-3-(methoxycarbonyl)phenylboronic acid)
• 850568-11-5(4-Ethoxycarbonyl-3-chlorophenylboronic acid)